ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Concepts Approved for Primary Care, Worker Health, Black Interventions

May 17, 1985

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial

June 28, 2002

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

No Recision Seen, New Money To Low In Mid-March

February 20, 1976

HHA “Investigative Memorandum” Revives Controversy Over AIDS Virus, Royalties

July 1, 1994